Real-time enrollment status for this diffuse large b-cell lymphoma clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:49 AM UTC
| NCT Number | NCT04920617 |
| Recruiting Status | Recruiting |
| Condition | Diffuse Large B-Cell Lymphoma |
| Phase | Clinical Trial |
| Target Enrollment | 102 participants |
| Active Locations | 17 sites in the US |
| Sponsor | ImmunoVaccine Technologies, Inc. (IMV Inc.) |
| Last Updated on CT.gov | April 7, 2023 (Apr 7, 2023) |
As of March 2, 2026: Clinical trial NCT04920617 is currently recruiting participants. This clinical trial study for diffuse large b-cell lymphoma is actively seeking new participants at 17 locations across the United States. The study is sponsored by ImmunoVaccine Technologies, Inc. (IMV Inc.). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04920617 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 17 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04920617 was last updated Apr 7, 2023 (April 7, 2023). HelloStudys verifies this status automatically.